FEATURED PUBLICATIONS
Showing 43 - 52 of 97
Published date : 25 March 2022
Myocardial Ischemia in the Management of Chronic Coronary Artery Disease: Past and Present
Angina
Stress-induced myocardial ischemia has long been considered important in the management of chronic coronary artery disease (CAD). The recently completed ISCHEMIA trial was designed to test the hypothesis that revascularization would improve outcomes in patients with moderate-severe ischemia on stress testing....
Reviewed by
S. Duarte
Published in
Circulation: Cardiovascular Imaging, volume 14 (2021)
Authors
Gibbons R.J., MSc, MD
Published date : 5 October 2021
Chronic coronary disease and diabetes: an invasive approach? Outcomes of Participants with Diabetes in the ISCHEMIA Trials
Angina
Among patients with diabetes mellitus (diabetes) and chronic coronary disease (CCD), it is unclear if invasive management improves outcomes when added to medical therapy. The ISCHEMIA Trials (ISCHEMIA and ISCHEMIA CKD) randomized CCD patients to an invasive (medical therapy + angiography...
Reviewed by
G. Bozet, MD
Published in
Cardiovasc Drugs Ther 2021
Authors
Newman JD, Anthopolos R, Mancini GBJ, et al
Published date : 5 October 2021
Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease
Angina
Optimal treatment strategy for managing stable ischemic heart disease is still a topic of debate. The purpose of this review by P. Vafaei et al. (Kaiser Permanente San Francisco Medical Center, California, USA) is to discuss treatment strategies for managing stable...
Reviewed by
D. Beard
Published in
Curr Atheroscler Rep 2021
Authors
Vafaei P, Naderi S, Ambrosy AP, et al
Published date : 5 September 2021
Implications of blinding: quality of life in trials of revascularisation for chronic stable angina
Angina
Chronic stable angina is estimated to affect over 9 million adults in the USA (a prevalence of 3.6%). It has a considerable impact on quality of life (QoL). The issues of symptoms improvement and quality of life (QoL) are critical for...
Reviewed by
G. Bozet, MD
Published in
Cardiovasc Drugs Ther 2021
Authors
Nowbar AN, Francis DP, Al-Lamee RK
Published date : 5 September 2021
Stable angina and NSTEMI: plaque distribution and target vessel vulnerability
Angina
There is very little data comparing plaque characteristics and wire-free physiological assessment in the target vessel in patients with stable angina versus acute coronary syndrome. In this study, K. Dan et al. (USA)investigated the difference in plaque distribution between stable angina...
Reviewed by
D. Beard
Published in
Coron Artery Dis 2021
Authors
Dan K, Garcia-Garcia HM, Yacob O, et al
Published date : 2 September 2021
The Priority of Non-HDL-C Assessment to Predict New Lesions among Stable Angina Patients with Strong Statins
Angina
Dyslipidemia is known to be significantly associated with an increased risk of CAD and lipid-lowering strategy is the key approach for primary and secondary prevention. In this cohort study, D. Kanda et al. (Kagoshima University, Japan) aimed to examine the clinical...
Reviewed by
G. Bozet, MD
Published in
J Atheroscler Thromb 2021
Authors
Kanda D, Miyata M, Ikeda Y, et al.
Published date : 2 September 2021
Blood urea nitrogen is associated with long-term all-cause mortality in stable angina pectoris patients: 8-year follow-up results
Angina
Elevation of blood urea nitrogen (BUN) indicates renal dysfunction and is associated with increased mortality in cardiovascular diseases. The authors investigated the relationship between the blood urea nitrogen concentration measured at hospital admission and the long-term all-cause mortality in 344 patients...
Reviewed by
D. Beard
Published in
Kardiologiia 2021
Authors
Çetin M, Erdoğan T, Özyıldız AG, et al.
Published date : 11 June 2021
Management of stable ischaemic heart disease: an overview
Angina
This article by Q. Radaideh et al. (Midwest Cardiovascular Research Foundation,USA) reviews the evidence on optimal medical therapy versus coronary revascularization in patients with stable ischaemic heart disease. Percutaneous coronary intervention is currently recommended for patients with significant left main disease,...
Reviewed by
D. Beard
Published in
Int J Angiol 2021
Authors
Radaideh Q, Shammas NW, Daher GE, et al
Published date : 11 June 2021
What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?
Angina
In this review, C. Berry et al. (British Heart Foundation, Glasgow, UK) consider the definitions of angina and myocardial ischaemia. They clarify pathophysiology, focusing on the mechanistic links between myocardial ischaemia and anginal symptoms, the difference between coronary heart disease and...
Reviewed by
G. Bozet, MD
Published in
Cardiovasc Drugs Ther 2021
Authors
Berry C, Morrow AJ, Marzilli M, et al
Published date : 31 May 2021
Meta-analysis of elective coronary revascularisation vs. medical therapy alone
Angina
E. Navarese et al. (Nicolaus Copernicus University, Poland) presented the results of a new meta-analysis of revascularisation plus medical therapy versus medical therapy alone in patients with chronic coronary syndromes. A total of 19,806 patients with chronic coronary syndromes undergoing elective...
Reviewed by
G. Bozet, MD
Published in
Navarese E et al
Authors
Euro PCR 2021